Healthcare Cross-Border M&A Between China, Israel and Russia

The global pandemic has forced the healthcare sector to reassess its approach to operations and its outlook for future transformations. M&A activity in the sector has slowed down, however, we can still see shorter-term deal tactics on the market. These will most probably be followed by more fundamental changes in deal strategies.

On September 15, at 11 am UTC+3 (4 pm Beijing time), we have organized an international webinar to discuss topics related to cross-border M&A in healthcare from the perspective of the following countries, China, Israel, Russia.

Agenda

• The prospective market situation of healthcare M&A in China, Israel and Russia.
• What are the key drivers and underlying motivations of buyers and sellers in three countries? What are the key success factors?
• Which key legal and regulatory considerations do healthcare companies need to make when undertaking transactions? Especially in the current situation.
• Which elements are key to M&A success in the sector?
• What are the potential trends or other key elements likely to impact at a market level?